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Abstract Leptin receptor gene expression has been measured in 
arcuate and ventromedial hypothalamic nuclei. Receptor mRNA 
in both hypothalamic areas was higher in obese mice than in lean 
littermates. Twice daily leptin administration for 7 days 
profoundly affected food intake, reduced leptin receptor mRNA 
in the arcuate nucleus, and had a similar effect on neuropeptide Y 
gene expression. A single leptin injection was ineffective. 
Exposure of lean mice to cold for 24 h caused an induction of 
leptin receptor and NPY mRNA which was normalized when 
animals were returned to the warm. Regulation of receptor gene 
expression may be an important component in the reading of the 
leptin signal. 
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1. Introduction 
Mutat ion of the obese gene and consequent leptin deficiency 
causes profound obesity in ob/ob mice [1]. Genetic leptin de-
ficiency gives rise to a number of obesity-related phenotypes 
which can be corrected by peripheral injection of recombinant 
murine leptin, resulting in weight loss, reduced food intake, 
increased metabolic rate, normalization of plasma hormone 
and metabolite concentrations [2-A], and stimulation of the 
reproductive endocrine system [5]. Initial evidence that leptin 
of adipose tissue origin might be active in the central nervous 
system came from study of the effects of administration into 
the ventricular system [4], which was followed by expression 
cloning of a leptin receptor gene from the choroid plexus [6]. 
Splice variants of the receptor exhibit a common extracellular 
sequence, but the Ob-Rb variant is distinguished by a long 
intracellular domain that is thought to be active in signal 
transduction [6-8]. The hypothalamus, a key integrative 
centre in energy homeostasis, was shown to express leptin 
receptor Ob-Rb m R N A , first by RT-PCR [6] and subse-
quently by in situ hybridization [9]. Leptin receptor gene ex-
pression was localized to a number of critical hypothalamic 
areas, including the arcuate (ARC), ventromedial (VMN) and 
paraventricular (PVN) nuclei [9]. Neuropeptide Y (NPY), 
which has potent effects on food intake and energy balance 
within the hypothalamus [10], is also abundantly expressed in 
the A R C . ob/ob mice exhibit elevated N P Y gene expression in 
the A R C , and in common with the other obesity-related phe-
notypes described above, leptin administration leads to a nor-
malization of the elevated m R N A level [11,12]. This effect is 
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likely to be through a direct mechanism, as we have shown 
recently that leptin receptor m R N A is co-expressed in N P Y 
neurons of the arcuate nucleus [13]. 
Cellular responses to leptin stimulation may be influenced 
by regulation of leptin receptor gene expression and protein 
levels. We hypothesized that the lack of functional circulating 
leptin in the ob/ob mouse could lead to differences in receptor 
gene expression in the hypothalamus between obese ob/ob 
mice and their lean littermates, and that this expression might 
be modulated by systemically administered leptin. We have 
also investigated the effect of cold exposure on leptin receptor 
gene expression. Leptin receptor gene expression was exam-
ined by in situ hybridization with probes for the common 
extracellular domain of the receptor (Ob-R) and its Ob-Rb-
specific intracellular domain [9]. 
2. Materials and methods 
2.1. Animals 
Lean (+/?) and obese (ob/ob) mice of the 'Aston' variety were drawn 
from a colony maintained at the Rowett Research Institute on a 12/12 
h light/dark cycle (lights on 07:00 h). Food (Biosure; SDS) and water 
were available ad libitum. All animals were killed by cervical disloca-
tion. Recombinant murine leptin was dissolved in bicarbonate buffer 
according to the manufacturer's instructions (Peprotech, London) and 
administered to obese animals by intraperitoneal (i.p.) injection. Three 
injection protocols were employed. In long-term studies of the effects 
of leptin on body weight and food intake, the peptide was adminis-
tered either twice daily at 09:00 h and 18:00 h for 7 days (1.25 ug/g 
body weight), or daily at 18:00 h for 5 days (2 ag/g body weight). The 
acute effects of a single leptin injection (1.25 ug/g body weight) early 
in the light phase were examined over a 5 h period in the absence of 
food. Some of the animals which received twice daily leptin injections 
for 7 days were injected with buffer vehicle for a further 6 days; 
control mice in all three leptin administration experiments also re-
ceived vehicle injections. In a separate experiment, energy flux was 
manipulated in lean mice by cold exposure, commencing early in 
the light phase. The effect of maintenance at 4°C for 24 h was com-
pared with control animals housed at 24°C and a group which was 
replaced at 24°C for 12 h following cold exposure for 24 h. 
2.2. In situ hybridization 
Leptin receptor gene expression in the ARC and VMN and NPY 
mRNA in the ARC of the mouse hypothalamus was examined in 
20 am coronal sections (corresponding to Fig. lc in [9]; equivalent 
to Bregma —3.3 to —2.8 in the rat brain according to [14]). In situ 
hybridization to sections mounted on poly(L-lysine)-coated slides em-
ployed techniques described in detail elsewhere [9,15]. Adjacent brain 
sections were hybridized with riboprobes for the common extracellu-
lar domain of the leptin receptor (Ob-R), the long form of the recep-
tor, Ob-Rb, and preproNPY mRNA. Leptin receptor cDNAs were 
cloned from the mouse as described previously [9]. NPY probes were 
generated from a 0.5 kb fragment of a rat NPY cDNA, kindly sup-
plied by Dr. Stephen Sabol [15]. Autoradiographic images were quan-
tified using the Bio Image system (Millipore). Data were standardized 
with 14C autoradiographic scales (Amersham, UK). Gene expression 
was measured as the integrated intensity of the autoradiographic sig-
nal (background-corrected OD integrated over all pixels in the hybrid-
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ization area). Two sections were analyzed from each brain and data 
from each hypothalamic region were averaged to yield a single value 
for expression of each mRNA species in each animal. Adjacent sec-
tions incubated with sense riboprobes yielded weak, non-specific, film 
images [9]. 
2.3. Statistical analysis 
Data were analyzed by /-tests or one-way analysis of variance fol-
lowed by multiple comparison procedures, as appropriate. Differences 
were considered statistically significant if/J < 0.05. Data are presented 
as means ± S.E. 
3. Results 
Brain sections which contained both the ARC and VMN 
were used in the quantification of leptin receptor gene expres-
sion. Probes for the common extracellular domain of the lep-
tin receptor (Ob-R) and the intracellular domain, Ob-Rb, re-
vealed a significant elevation in receptor gene expression in 
obese (oblob) mice compared with their lean, age-matched, 
littermates; receptor mRNA levels were increased in both 
the ARC and VMN (Fig. 1). Obese mice also exhibited ele-
vated NPY gene expression in the ARC. Elevated expression 
of the leptin receptor gene in the oblob mouse may be due to 
the absence of functional leptin in this obese model. This 
possibility was investigated by administration of recombinant 
murine leptin or buffer vehicle to obese mice. 
When leptin was administered by twice daily injection for 7 
days (LEP-treated), voluntary food intake fell rapidly from a 
daily intake of approx. 8 g to a new, relatively stable, level of 
1.5-2.5 g (Fig. 2). When leptin was withdrawn, but injection 
of vehicle continued for a further 6 days (LEP/VEH-treated), 
intake returned to levels exhibited by obese control mice 
(VEH-treated controls; Fig. 2). These changes in intake con-
tributed to a 19% reduction in body weight during the leptin 
treatment period (mean body weights, 76.4 g vs 61.9 g); ap-
prox. 40% of this weight loss was restored during the subse-
quent 6 days of vehicle injections. Using the Ob-R probe, 
there was a significant effect of treatment on leptin receptor 
gene expression in the ARC, but not in the VMN (Fig. 3). 
Mice treated with leptin for 7 days (LEP-treated) had lower 
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Fig. 2. Effect of twice daily i.p. injections of leptin on food intake of obese oblob mice. Injections started on day 0. Mice injected with leptin 
(1.25 |j,g/g body weight) twice daily for 7 days (LEP-treated) were compared with controls injected with buffer vehicle (VEH-treated), and with 
animals where leptin treatment was followed by vehicle injections for a further 6 days (LEP/VEH-treated). LEP-treated and VEH-treated 
groups contained 5 animals. The LEP/VEH-treated group contained 4 animals. 
Fig. 1. Leptin receptor and NPY gene expression in the ARC and 
VMN of lean and obese (oblob) mice. Leptin receptor mRNA was 
measured with probes to the common leptin receptor sequence, Ob-
R, and the Ob-Rb splice variant. Data from obese mice are ex-
pressed as a percent of lean controls. Groups contained 5 animals. 
levels of Ob-R mRNA in the ARC than VEH-treated con-
trols, however, differences between these groups and mice 
where leptin treatment was followed by 6 days of vehicle 
treatment (LEP/VEH-treated) were not statistically signifi-
cance. Adjacent sections were hybridized with the Ob-Rb-spe-
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Fig. 3. Effect of twice daily i.p. injections of leptin on leptin recep-
tor and NPY gene expression in the ARC and VMN of obese oblob 
mice. Mice injected with leptin (1.25 ug/g body weight) twice daily 
for 7 days (LEP-treated) were compared with controls injected with 
buffer vehicle (VEH-treated), and with animals where leptin treat-
ment was followed by vehicle injections for a further 6 days (LEP/ 
VEH-treated). Data from LEP-treated and LEP/VEH-treated mice 
are expressed as a percent of VEH-treated controls. Other details as 
in legend to Fig. 2. 
warm. The induction of leptin receptor gene expression by 
cold exposure was apparent throughout the ARC, although 
the data presented here relate to a discrete region of this 
nucleus; increased receptor mRNA in the ARC of the obese 
mouse (Fig. 1) and reductions induced by leptin administra-
tion (Fig. 3) were also uniform changes. Differences in leptin 
receptor gene expression in the VMN due to cold exposure, 
and in the ARC when probed for the Ob-Rb splice variant, 
failed to attain statistical significance (Fig. 4). 
4. Discussion 
The failure of the obese oblob mouse to synthesize func-
tional leptin releases the leptin receptor from its normal stim-
ulus, and this presumably accounts for elevated receptor 
mRNA levels in the hypothalamus of the obese animal; 
both the ARC and the VMN exhibit this effect (Fig. 1). Neu-
ropeptide Y gene expression is also elevated in the ARC of 
obese oblob mice, and previous studies have demonstrated 
that systemic leptin administration to the oblob mouse reduces 
this elevated expression of NPY [11,12]. We have extended 
this observation by demonstrating a reduction in leptin recep-
tor gene expression in the ARC when leptin is administered 
either twice or once daily over a period of several days (Fig. 
cific riboprobe. Significant differences were observed between 
all three treatment groups in expression of the long splice 
variant of the leptin receptor gene in the ARC (Fig. 3); trends 
in the VMN again failed to attain statistical significance. The 
reduction in Ob-Rb mRNA in the ARC of LEP-treated mice 
and its relative normalization when leptin treatment was ter-
minated (LEP/VEH-treated) was accompanied by similar 
changes in NPY gene expression in this nucleus; LEP-treated 
mice had lower levels of NPY mRNA than the other two 
treatment groups (Fig. 3). 
Once daily injection of obese oblob mice with a larger dose 
of recombinant leptin for 5 days also decreased food intake, 
body weight, and leptin receptor gene expression in the ARC 
(results not shown). Changes in food intake were less pro-
nounced than with twice daily injection and body weight de-
creased by 6% in leptin-treated mice. 5 h after administration, 
there was no effect of a single injection of recombinant murine 
leptin on leptin receptor or NPY gene expression in obese obi 
ob mice (results not shown). 
Energy balance and energy flux were manipulated by hous-
ing lean mice at 4°C for 24 h (cold-exposed). A second group 
of animals was returned to 24°C for 12 h following cold ex-
posure (rewarmed). Exposure to cold had a significant effect 
on Ob-R (p < 0.05) and NPY (p < 0.01) gene expression in the 
ARC (Fig. 4); cold-exposed mice had higher levels of Ob-R 
and NPY mRNA than controls or animals returned to the 
Fig. 4. Effect of cold-exposure (cold-exposed) or rewarming follow-
ing cold exposure (rewarmed) on leptin receptor and NPY gene ex-
pression in the ARC and VMN of lean mice. Data from cold-ex-
posed and rewarmed mice are expressed as a percent of controls 
maintained at 24°C throughout. Groups contained 5 animals. 
188 J.G. Mercer et al.lFEBS Letters 402 (1997) 185-188 
3). Although similar trends were observed, the failure of the 
VMN to exhibit significant changes in receptor gene expres-
sion following leptin injection may be due to lower concen-
trations of leptin reaching this nucleus. Following intravenous 
injection, [125I]leptin is taken up by the ARC, median emi-
nence and choroid plexus [16], but outside these areas, uptake 
is diffuse. When leptin treatment was terminated, the inhibi-
tory regulation of leptin receptor and NPY gene expression 
was removed (Fig. 3). A single systemic injection of leptin 
early in the light phase failed to reduce leptin receptor or 
NPY gene expression, and the duration of leptin administra-
tion (or dose) required to induce changes in gene expression 
remains to be determined; it is possible that transport across 
the blood-brain barrier is rate-limiting. 
Although leptin regulates receptor mRNA level in the oblob 
mouse, the response of gene expression to fluctuating plasma 
leptin concentrations in the normal lean animal may be more 
significant. We employed cold exposure in the lean mouse as 
an energetic manipulation which rapidly alters leptin signals 
arising from adipose tissue. Exposure of lean mice to cold 
leads to complete disappearance of ob mRNA in adipose tis-
sue within hours [17], a change which is more profound than 
that observed with fasting and which is likely to reduce leptin 
synthesis. This is demonstrated by lean rats, where plasma 
leptin is reduced by cold-exposure [18]. Effects of cold on ob 
mRNA and plasma leptin are reversible during short periods 
at 24°C [17,18]. The increase in Ob-R mRNA in the ARC of 
cold-exposed lean mice, and the reversible nature of this in-
duction, supports the contention that leptin receptor gene ex-
pression is regulated by plasma leptin concentration in the 
lean mouse. However, an indirect effect of cold exposure on 
receptor gene expression, such as via the stress axis, cannot be 
ruled out. We also observed elevated NPY gene expression in 
the ARC of the cold-exposed mouse (Fig. 4), which was nor-
malized on return to the warm. These data, reflecting negative 
energy balance, are consistent with increases in NPY peptide 
concentration in a number of hypothalamic regions in rats 
exposed to cold for 18 h [19]. 
A major component of the biological activity of leptin ap-
pears to involve interactions within the hypothalamus. Our 
data from the oblob mouse (Figs. 1 and 3) show regulation 
of hypothalamic receptor mRNA in response to leptin. 
Although the presumptive leptin binding protein in the cho-
roid plexus does not possess the intracellular signaling do-
main, binding studies in oblob and dbldb mice suggest that 
leptin deficiency or severe hyperleptinemia might regulate re-
ceptor numbers [20,21]. Thus, at least in the obese mouse, 
there is evidence that receptor activation results in regulation 
both at the protein level and at the level of gene expression. 
These changes are likely to be transient in nature, being re-
versible once leptin is withdrawn (Fig. 3). The rapid and re-
versible induction of hypothalamic leptin receptor gene ex-
pression in leptin-competent animals in which the leptin 
signal was manipulated by exposure to cold (Fig. 4) indicates 
that receptor regulation is likely to be an important mecha-
nism for regulating the leptin signal and thus subsequent cel-
lular activation in the normal animal. It is recognized, how-
ever, that the speed of receptor turnover will be an important 
component in determining whether relatively rapid changes in 
leptin receptor mRNA are translated into changes in receptor 
density. Differences in the degree of induction of receptor 
mRNA detected with either the Ob-R or the Ob-Rb probes 
in obese mice (Fig. 1) and cold-exposed lean mice (Fig. 4) may 
reflect a mixed population of receptor mRNA splice variants 
in the ARC. The fact that NPY gene expression changes in 
parallel to leptin receptor mRNA under different circumstan-
ces provides further evidence for an interaction between these 
signaling pathways in the hypothalamus [13]. In conclusion, 
regulation of the receptor gene expression may prove to be an 
important component in the regulation of the leptin signal. 
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